1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection

The outbreak of SARS-CoV-2 virus caused more than 80,155,187 confirmed COVID-19 cases worldwide, which has posed a serious threat to global public health and the economy. The development of vaccines and discovery of novel drugs for COVID-19 are urgently needed. Although the FDA-approved SARS-CoV-2 v...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rui Hong, Yang, Li Jun, Hamdoun, Sami, Chung, Sookja Kim, Lam, Christopher Wai-kei, Zhang, Kai Xi, Guo, Xiaoling, Xia, Chenglai, Law, Betty Yuen Kwan, Wong, Vincent Kam Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058605/
https://www.ncbi.nlm.nih.gov/pubmed/33897423
http://dx.doi.org/10.3389/fphar.2021.634176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058605/
https://www.ncbi.nlm.nih.gov/pubmed/33897423
http://dx.doi.org/10.3389/fphar.2021.634176

Ejemplares similares